NDC 59262-701 Ivizia Lubricant Eye For Severe Night Dry Eyes

Povidone Solution, Gel Forming / Drops Ophthalmic - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
59262-701
Proprietary Name:
Ivizia Lubricant Eye For Severe Night Dry Eyes
Non-Proprietary Name: [1]
Povidone
Substance Name: [2]
Povidone, Unspecified
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Solution, Gel Forming / Drops - A solution, which after usually being administered in a drop-wise fashion, forms a gel.
Administration Route(s): [4]
  • Ophthalmic - Administration to the external eye.
  • Labeler Code:
    59262
    FDA Application Number: [6]
    M018
    Marketing Category: [8]
    OTC MONOGRAPH DRUG -
    Start Marketing Date: [9]
    10-14-2021
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 59262-701?

    The NDC code 59262-701 is assigned by the FDA to the product Ivizia Lubricant Eye For Severe Night Dry Eyes which is a human over the counter drug product labeled by Similasan Corporation. The generic name of Ivizia Lubricant Eye For Severe Night Dry Eyes is povidone. The product's dosage form is solution, gel forming / drops and is administered via ophthalmic form. The product is distributed in a single package with assigned NDC code 59262-701-12 30 vial, single-use in 1 carton / .4 g in 1 vial, single-use. This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Ivizia Lubricant Eye For Severe Night Dry Eyes?

    Gel is particularly suited for severe dry eye or nighttime use.Wash hands well before use.Take one single-use vial off the strip. Turn upside down, tap the vial and twist off the top.Instill 1 or 2 drops in the affected eye(s) as needed.If you wear contact lenses: you must remove them before using iVIZIA gel. After use wait at least 30 minutes before putting your lenses back in.

    What are Ivizia Lubricant Eye For Severe Night Dry Eyes Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • POVIDONE, UNSPECIFIED 2.5 mg/.5g - A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.

    Which are Ivizia Lubricant Eye For Severe Night Dry Eyes UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Ivizia Lubricant Eye For Severe Night Dry Eyes Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Ivizia Lubricant Eye For Severe Night Dry Eyes?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".